期刊
ACTA PSYCHIATRICA SCANDINAVICA
卷 132, 期 -, 页码 1-28出版社
WILEY
DOI: 10.1111/acps.12479
关键词
psychotropic drugs; pregnancy; breast-feeding; clinical guidelines; recommendations
类别
资金
- Bristol-Myers Squibb
- Astra Zeneca
- Janssen Cilag
- Servier
- Otsuka Pharmaceuticals
- Eli Lilly
ObjectiveTo write clinical guidelines for the use of psychotropic drugs during pregnancy and breast-feeding for daily practice in psychiatry, obstetrics and paediatrics. MethodAs we wanted a guideline with a high degree of consensus among health professionals treating pregnant women with a psychiatric disease, we asked the Danish Psychiatric Society, the Danish Society of Obstetrics and Gynecology, the Danish Paediatric Society and the Danish Society of Clinical Pharmacology to appoint members for the working group. A comprehensive review of the literature was hereafter conducted. ResultsSertraline and citalopram are first-line treatment among selective serotonin reuptake inhibitor for depression. It is recommended to use lithium for bipolar disorders if an overall assessment finds an indication for mood-stabilizing treatment during pregnancy. Lamotrigine can be used. Valproate and carbamazepin are contraindicated. Olanzapine, risperidone, quetiapine and clozapine can be used for bipolar disorders and schizophrenia. ConclusionIt is important that health professionals treating fertile women with a psychiatric disease discuss whether psychotropic drugs are needed during pregnancy and how it has to be administered.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据